Clinical significance of the increased Multidrug Resistance-associated Protein (MRP) gene expression in patients with primary breast cancer

Oncology Research

Volumn 10, Issue 2, 1998, Pages 99-109

  Ito, Ken Ichi ^a   Fujimori, Minoru ^a   Nakata, Shinji ^a   Hama, Yoshihisa ^a   Shingu, Kiyoshi ^a   Kobayashi, Shinya ^a   Tsuchiya, Shin Ichi ^b   Kohno, Kimitoshi ^c   Kuwano, Michihiko ^d   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagano Cancer Detection Center   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Multidrug resistance (MDR); Multidrug resistance associated protein (MRP); Polymerase chain reaction (PCR); Topoisomerase

Indexed keywords

ABC TRANSPORTER; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST; BREAST TUMOR; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; BREAST; BREAST NEOPLASMS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RETROSPECTIVE STUDIES;

EID: 0031603871     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Scotto, K. W.; Biedler, J. L.; Melera, P. W. Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 232:751-755; 1986.
2. Endicott, J.; Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137-171; 1989.
3. Gottesman, M. M.; Pastan, I. The multidrug transporter, a double-edged sword. J. Biol. Chem. 263:12163-12166; 1988.
4. Verrelle, P.; Meissonnier, Y. F.; Feillel, V.; Dionet, C.; Kwiatkowski, F.; Plagne, R.; Chassagne, J. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J. Natl. Cancer Inst. 83:111-116; 1991.
5. Linn, S. C.; Giaccone, G.; van Diest, P. J.; Blokhuis, W. M. D.; van der Valk, P.; van Kalken, C. K.; Kuiper, C. M.; Pinedo, H. M.; Baak, J. P. A. Prognostic relevance of P-glycoprotein expression in breast cancer. Ann. Oncol. 6:679-685; 1995.
6. Decker, D. A.; Morris, L. W.; Levine, A. J.; Pettinga, J. E.; Grudzien, J. L.; Farkas, D. H. Immunohistochemical analysis of P-glycoprotein expression in breast cancer: Clinical correlations. Ann. Clin. Lab. Sci. 25:52-59; 1995.
7. Wallner, J.; Depisch, D.; Hopfner, M.; Haider, K.; Spona, J.; Ludwig, H.; Pirker, R. MDR1 gene expression and prognostic factors in primary breast carcinomas. Eur. J. Cancer 27:1352-1355; 1991.
8. Goldstein, L. J.; Galski, H.; Fojo, A.; Willingham, M.; Lai, S.-L.; Gazdar, A.; Pirker, R.; Green, A.; Crist, W.; Brodeur, G. M.; Lieber, M.; Cossman, J.; Gottesman, M. M.; Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81:116-124; 1989.
9. Merkel, D. E.; Fuqua, S. A. W.; Tandon, A. K.; Hill, S. M.; Buzdar, A. U.; McGuire, W. L. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression of gene amplification. J. Clin. Oncol. 7:1129-1136; 1989.
10. van der Valk, P.; van Kalken, C. K.; Ketelaars, H. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Ann. Oncol. 1:56-64; 1990.
11. Beck, W. T.; Grogan, T. M.; Willman, C. L.; Cordon-Cardo, C.; Parham, D. M.; Kuttesch, J. F.; Andreeff, M.; Bates, S. E.; Berard, C. W.; Boyett, J. M.; Brophy, N. A.; Broxterman, H. J.; Chan, H. S. L.; Dalton, W. S.; Dietel, M.; Fojo, A. T.; Gascoyne, R. D.; Head, D.; Houghton, P. J.; Srivastava, D. K.; Lehnert, M.; Leith, C. P.; Paietta, E.; Pavelic, Z. P.; Rimsza, L.; Roninson, I. B.; Sikic, B. I.; Twentyman, P. R.; Warnke, R.; Weinstein, R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations. Cancer Res. 56: 3010-3020; 1996.
12. de-Jong, S.; Zijlstra, J. G.; de-Vries, E. G.; Mulder, N. H. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 50:304-309; 1990.
13. Takano, H.; Kohno, K.; Ono, M.; Uchida, Y.; Kuwano, M. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res. 51:3951-3957; 1991.
14. Isaacs, R. J.; Davies, S. L.; Wells, N. J.; Harris, A. L. Topoisomerase IIα and β as therapy targets in breast cancer. Anticancer Drugs 6:195-211; 1995.
15. Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cell line. Science 258:1650-1654; 1992.
16. Grant, C. E.; Valdimarsson, G.; Hipfner, D. R.; Almquist, K. C.; Cole, S. P. C.; Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:357-361; 1994.
17. Nooter, K.; Westerman, A. M.; Flens, M. J.; Zaman, G. J. R.; Scheper, R. J.; van Wingerden, K. E.; Burger, H.; Oostrum, R.; Boersma, T.; Sonneveld, P.; Gratama, J. W.; Kok, T.; Eggermont, A. M. M.; Bosman, F. T.; Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res. 1:1301-1310; 1995.
18. Ota, E.; Abe, Y.; Oshika, Y.; Ozeki, Y.; Iwasaki, M.; Inoue, H.; Yamazaki, H.; Ueyama, Y.; Takagi, K.; Ogata, T.; et, a. l. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer 72:550-554; 1995.
19. Bordow, S. B.; Haber, M.; Madafiglio, J.; Cheung, B.; Marshall, G. M.; Norris, M. D. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res. 53:5036-5040; 1994.
20. Norris, M. D.; Bordow, S. B.; Marshall, G. M.; Haber, P. S.; Cohn, S. L.; Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med. 334:231-238; 1996.
21. Filipits, M.; Suchomel, R. W.; Dekan, G.; Haider, K.; Valdimarsson, G.; Depisch, D.; Pirker, R. MRP and MDR1 gene expression in primary breast carcinomas. Clin. Cancer Res. 2:1231-1237; 1996.
22. Nooter, K.; Bosman, F. T.; Burger, H.; van Wingerden, K. E.; Flens, M. J.; Scheper, R. J.; Oostrum, R. G.; Boersma, A. W. M.; van der Gaast, A.; Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann. Oncol. 7:75-81; 1996.
23. Clifford, S. C.; Neal, D. E.; Lunec, J. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. Br. J. Cancer 73: 659-666; 1996.
24. Bloom, H. J. G.; Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer 11:359-377; 1957.
25. Nakagawa, M.; Emoto, A.; Nasu, N.; Hanada, T.; Kuwano, M.; Cole, S. P. C.; Nomura, Y. Clinical significance of multidrug resistance-associated protein (MRP) and P-glycoprotein in patients with bladder cancer. J. Urol. 157:1260-1264; 1997.
26. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159; 1987.
27. Noonan, K. E.; Beck, C.; Holzmayer, J. A.; Chin, J. E.; Wunder, J. S.; Andrulis, I. L.; Gazdar, A. F.; Willman, C. L.; Griffith, B.; Von Hoff, D. D.; Roninson, I. B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:7160-7164; 1990.
28. Schneider, E.; Horton, J. K.; Yang, C.-H.; Nakagawa, M.; Cowan, K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 54:152-158; 1994.
29. Beck, J.; Handgretinger, R.; Klingebiel, T.; Dopfer, R.; Schaich, M.; Ehninger, G.; Niethammer, D.; Gekeler, V. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia 10:426-433; 1996.
30. Herber, B.; Truss, M.; Beato, M.; Mueller, R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-1304; 1994.
31. Kwok, S.; Higuchi, R. Avoiding false positives with PCR. Nature 339:237-238; 1989.
32. Kruh, G. D.; Chan, A.; Myers, K.; Gaughan, K.; Miki, T.; Aaronson, S. A. Expression complementary DNA library transfer establishes MRP as a mullidrug resistance gene. Cancer Res. 54:1649-1652; 1994.
33. Zaman, G. J. R.; Flens, M. J.; van Leusden, M. R.; de Haas, M.; Müder, H. S.; Lankelma, J.; Pinedo, H. M.; Scheper, R. J.; Baas, F.; Broxterman, H. J.; Borst, P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA 91:882-886; 1994.
34. Cole, S. P.; Sparks, K. E.; Fraser, K.; Loe, D. W.; Grant, C. E.; Wilson, G. M.; Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902-5910; 1994.
35. Abe, T.; Hasegawa, S.; Taniguchi, K.; Yokomizo, A.; Kuwano, T.; Ono, M.; Mori, T.; Hori, S.; Kohno, K.; Kuwano, M. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int. J. Cancer 58: 860-864; 1994.
36. Hasegawa, S.; Abe, T.; Naito, S.; Kotoh, S.; Kumazawa, J.; Hipfner, D. R.; Deeley, R. G.; Cole, S. P.; Kuwano, M. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br. J. Cancer 71:907-913; 1995.
37. Koike, K.; Abe, T.; Hisano, T.; Kubo, T.; Wada, M.; Kohno, K.; Kuwano, M. Overexpression of multidrug resistance protein gene in human cancer cell lines selecled for drug resistance to epipodophyllotoxins. Jpn. J. Cancer Res. 87:765-772; 1996.
38. Burger, H.; Nooter, K.; Sonneveld, P.; Van, W. K.; Zaman, G. J.; Stoter, G. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. Br. J. Haematol. 88:348-356; 1994.
39. Schneider, E.; Cowan, K. H.; Bader, H.; Toomey, S.; Schwartz, G. N.; Karp, J. E.; Burke, P. J.; Kaufmann, S. H. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85:186-193; 1995.
40. Brophy, N. A.; Marie, J. P.; Rojas, V. A.; Warnke, R. A.; McFall, P. J.; Smith, S. D.; Sikic, B. I. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: A critical evaluation by four techniques. Leukemia 8:327-335; 1994.
41. Charpin, C.; Vielh, P.; Duffaud, F.; Devictor, B.; Andrac, L.; Lavaut, M. N.; Allasia, C.; Horschowski, N.; Piana, L. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: Correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J. Natl. Cancer Inst. 86:1539-1545; 1994.
42. Loe, D. W.; Deeley, R. G.; Cole, S. P. C. Biology of the multidrug resistance protein, MRP. Eur. J. Cancer 32A:945-957; 1996.
43. Kohno, K.; Sato, S.; Takano, H.; Matsuo, K.; Kuwano, M. The direct activation of human multidrug resistance gene (MDR1) by anticancer asents. Biochem. Biophys. Res. Commun. 165:1415-1421; 1989.
44. Uchiumi, T.; Kohno, K.; Tanimura, H.; Matsuo, K.; Sato, S.; Uchida, Y.; Kuwano, M. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ. 4:147-157; 1993.
45. Smith, K.; Houlbrook, S.; Greenall, M.; Carmichael, J.; Harris, A. L. Topoisomerase II alpha co-amplification with 3rbB2 in human primary breast cancer and breast cancer cell lines: Relationship to m-AMSA and miloxantrone sensitivity. Oncogene 8:933-938; 1993.
46. Tuccari, G.; Rizzo, A.; Giuffré, G.; Barresi, G. Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: Correlation with clinico-pathological features. Virchows Archiv. A Pathol. Anat. 423:51-55; 1993.
47. Matsuo, K.; Kohno, K.; Takano, H.; Sato, S.; Kiue, A.; Kuwano, M. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines. Cancer Res. 50:5819-5824; 1990.
48. Matsuo, K.; Kohno, K.; Sato, S.; Uchiumi, T.; Tanimura, H.; Yamada, Y.; Kuwano, M. Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells. Cancer Res. 53:1085-1090; 1993.
49. Beck, W. T.; Danks, M. K. Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II. In: Liu, L. F., eds. DNA topoisomerases; topoisomerase-targeting drugs. Boston: Academic Press; 1994:145-169.
50. Husain, I.; Mohler, J. L.; Seigler, H. F.; Besterman, J. M. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: Demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 54:539-546; 1994.
51. Giovenella, B. C.; Steblin, J. S.; Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Liu, L. F.; Silber, R.; Pomesil, M. DNA topoisomerase I targeted chemotherapy of human colon cancer in xenografts. Science 246:1046-1048; 1989.
52. Lammie, G. A.; Fantl, V.; Smith, R.; Schuuring, E.; Brookes, S.; Michalides, R.; Dickson, C.; Arnold, A.; Peters, G. D11S287, a putative oncogene on chromosome IIq13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444; 1991.
53. Buckley, M. F.; Sweeney, K. J. E.; Hamilton, J. A.; Sini, R. L.; Manning, D. L.; Nicholson, R. I.; deFazio, A.; Watts, C. K. W.; Musgrove, E. A.; Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133; 1993.